Clinical Trial Update: Omega 3 Fatty Acids in Patients With Chronic Renal Disease [Phase 3]

View source ↗

Summary

Phase 3 trial updating results for omega-3 fatty acids in patients with chronic renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Insufficiency Chronic

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of Chile | Conditions: Renal Insufficiency, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2019-09-09